Cytosorbents Corporation (CTSO) vs Lantern Pharma Inc. (LTRN)
A side-by-side comparison of Cytosorbents Corporation and Lantern Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTSO
Cytosorbents Corporation
$4.01HealthcareDelayed quote: Oct 6, 2026, 11:46 AM EDT
LTRN
Lantern Pharma Inc.
$1.02HealthcareDelayed quote: Oct 6, 2026, 12:13 PM EDT
Total return — CTSO vs LTRN
growth of $100 · dividends reinvested · last 6yCTSO -97.7% (-46.8%/yr)LTRN -93.7% (-36.9%/yr)LTRN compounded faster over this window
CTSO LTRN
CTSO vs LTRN: by the numbers
- •LTRN is the larger company ($13M vs $13M market cap).
- •Both run net losses; LTRN's is the smaller (0.00% vs -48.94% net margin).
Metrics side by side
Valuation
| Metric | CTSO | LTRN |
|---|---|---|
| P/S ratio | 0.34 | N/A |
Profitability
| Metric | CTSO | LTRN |
|---|---|---|
| Gross margin | 71.61% | 0.00% |
| Operating margin | -33.37% | 0.00% |
| Net margin | -48.94% | 0.00% |
| ROIC | -43.31% | -358.04% |
Growth (annualized)
| Metric | CTSO | LTRN |
|---|---|---|
| Revenue CAGR (5Y) | -3.17% | N/A |
| Total return CAGR (5Y) | -52.26% | -37.05% |
Frequently asked
- How have CTSO and LTRN total returns compared?
- Over the past 5 years, CTSO delivered -52.26% and LTRN delivered -37.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.